Treatment of Acute Lymphoid Leukemia Refractory to Classic First-Line and Rescue Protocols

Int J Hematol Oncol Stem Cell Res. 2020 Apr 1;14(2):123-126.

Abstract

Acute Lymphoblastic Leukemia is a very aggressive malignant disorder of lymphoid cells in adults, with recurrence (30 to 60% of the cases) after the initial treatment. Until this moment, there is no gold standard therapy for the treatment of adult patients with acute relapsed/refractory lymphoblastic leukemia. In this case report, we describe two cases of relapsed leukemia: one of lymphocytic leukemia B and one of trilineage leukemia, which presented a satisfactory response to treatment with Bortezomib associated with Vincristine, Dexamethasone, and Bendamustine.

Keywords: Acute lymphoblastic leukemia; Lymphoid cells; Relapsed leukemia.

Publication types

  • Case Reports